CPMD
CannaPharmaRX, Inc.
Price Chart
Latest Quote
$0.00
+0.00 (+0.00%)
Current Price
| Previous Close | $0.00 |
| Open | $0.00 |
| Day High | $0.00 |
| Day Low | $0.00 |
| Volume | 6,000 |
Stock Information
| Shares Outstanding | 678.50M |
| Total Debt | $25.45M |
| Cash Equivalents | $633 |
| Revenue | $1.65M |
| Net Income | $-10.82M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $1.70M |
| EPS (TTM) | $-0.02 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $27.76M |
| Sales | $1.65M |
| Income | $-10.82M |
| Book/sh | $-0.05 |
| Cash/sh | $0.00 |
| Employees | 26 |
Financial Ratios
| Quick Ratio | 0.00 |
| Current Ratio | 0.03 |
Returns & Margins
| ROA | -23.52% |
| Gross Margin | -146.68% |
| Operating Margin | -108.75% |
Ownership
| Insider Ownership | 6.76% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 1.03 |
| P/B | -0.05 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.00 |
| SMA50 | $0.00 |
| SMA200 | $0.00 |
| RSI | 46.43 |
| ATR | 0.0011 |
| Shares Float | 623.90M |
| Volatility | -1571.78 |
Performance History
| Week | -3.85% |
| Month | -32.43% |
| Quarter | -43.18% |
| 6 Months | -44.44% |
| YTD | -71.59% |
| Year | -37.50% |
| 3 Years | -65.75% |
| 5 Years | -96.69% |
| 10 Years | -99.41% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-17 | $0.00 | 0 |
| 2026-06-16 | $0.00 | 193,645 |
| 2026-06-15 | $0.00 | 22,100 |
| 2026-06-12 | $0.00 | 798,180 |
| 2026-06-11 | $0.00 | 40,000 |
| 2026-06-10 | $0.00 | 6,100 |
| 2026-06-09 | $0.00 | 580 |
| 2026-06-08 | $0.00 | 60,667 |
| 2026-06-05 | $0.00 | 0 |
| 2026-06-04 | $0.00 | 6,002 |
| 2026-06-03 | $0.00 | 793,517 |
| 2026-06-02 | $0.00 | 1,000 |
| 2026-06-01 | $0.00 | 917,445 |
| 2026-05-29 | $0.00 | 2,451,702 |
| 2026-05-28 | $0.00 | 261,477 |
| 2026-05-27 | $0.00 | 2,000 |
| 2026-05-26 | $0.00 | 71,099 |
| 2026-05-22 | $0.00 | 0 |
| 2026-05-21 | $0.00 | 0 |
| 2026-05-20 | $0.00 | 1,500 |
| 2026-05-19 | $0.00 | 1,112,000 |
| 2026-05-18 | $0.00 | 294,350 |
About CannaPharmaRX, Inc.
CannaPharmaRX, Inc. engages in acquisition, development, and operation of cannabis cultivation facilities in Germany, Israel, Portugal, and Canada. It produces and sells dried cannabis flower and trim shake, as well as unique genetics, medical cannabis, and craft products. The company is based in Cremona, Canada.
đ° Latest News
No news articles available at the moment. Check back later for updates on CPMD.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $3,755,064 | $0 | - | - |
| Cost Of Revenue | $3,755,064 | $0 | - | - |
| Total Revenue | $820,137 | $0 | $0 | $0 |
| Operating Revenue | $820,137 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $2,264,095 | $1,690,924 | $2,290,319 | $1,507,391 |
| Total Expenses | $4,426,394 | $1,581,104 | $5,211,809 | $2,616,470 |
| Rent Expense Supplemental | $4,381 | $2,599 | $12,307 | $0 |
| Other Income Expense | $-4,035,437 | $6,960,484 | $-1,028,892 | $-4,708,638 |
| Other Non Operating Income Expenses | $-3,449,789 | $401,778 | $402,394 | - |
| Net Non Operating Interest Income Expense | $-2,264,095 | $-1,690,924 | $-2,290,319 | $-1,507,391 |
| Interest Expense Non Operating | $2,264,095 | $1,690,924 | $2,290,319 | $1,507,391 |
| Operating Expense | $671,330 | $1,581,104 | $5,211,809 | $2,616,470 |
| General And Administrative Expense | $671,330 | $1,453,257 | $4,905,989 | $2,599,398 |
| Other Operating Expenses | - | - | $10,886 | $14,364 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-9,905,789 | $3,688,456 | $-8,531,020 | $-8,832,499 |
| Net Interest Income | $-2,264,095 | $-1,690,924 | $-2,290,319 | $-1,507,391 |
| Normalized Income | $-9,320,141 | $-246,768 | $-7,099,734 | $-4,123,861 |
| Net Income From Continuing And Discontinued Operation | $-9,905,789 | $3,688,456 | $-8,531,020 | $-8,832,499 |
| Total Operating Income As Reported | $-3,606,257 | $-1,581,104 | $-5,211,809 | $-2,993,169 |
| Net Income Common Stockholders | $-9,905,789 | $3,688,456 | $-8,531,020 | $-8,832,499 |
| Net Income | $-9,905,789 | $3,688,456 | $-8,531,020 | $-8,832,499 |
| Net Income Including Noncontrolling Interests | $-9,905,789 | $3,688,456 | $-8,531,020 | $-8,832,499 |
| Net Income Continuous Operations | $-9,905,789 | $3,688,456 | $-8,531,020 | $-8,832,499 |
| Pretax Income | $-9,905,789 | $3,688,456 | $-8,531,020 | $-8,832,499 |
| Special Income Charges | $-690,712 | $6,814,226 | $-929,912 | $-1,205,775 |
| Operating Income | $-3,606,257 | $-1,581,104 | $-5,211,809 | $-2,616,470 |
| Depreciation Amortization Depletion Income Statement | $0 | $127,847 | $294,934 | $2,708 |
| Depreciation And Amortization In Income Statement | $0 | $127,847 | $294,934 | $2,708 |
| Gross Profit | $-2,934,927 | $0 | - | - |
| Depreciation Income Statement | - | - | $294,934 | $2,708 |
| Per Share | ||||
| Diluted EPS | $-0.02 | $0.01 | $-0.04 | $-0.12 |
| Basic EPS | $-0.02 | $0.01 | $-0.04 | $-0.12 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $2,623,482 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-7,056,046 | $-1,051,479 | $-4,514,481 | $-2,613,762 |
| Total Unusual Items | $-585,648 | $6,558,706 | $-1,431,286 | $-4,708,638 |
| Total Unusual Items Excluding Goodwill | $-585,648 | $6,558,706 | $-1,431,286 | $-4,708,638 |
| Reconciled Depreciation | $0 | $127,847 | $294,934 | $2,708 |
| EBITDA (Bullshit earnings) | $-7,641,694 | $5,507,227 | $-5,945,767 | $-7,322,400 |
| EBIT | $-7,641,694 | $5,379,380 | $-6,240,701 | $-7,325,108 |
| Diluted Average Shares | $625,276,406 | $308,937,710 | $211,044,357 | $74,686,563 |
| Basic Average Shares | $625,276,406 | $308,937,710 | $211,044,357 | $74,686,563 |
| Diluted NI Availto Com Stockholders | $-9,905,789 | $3,688,456 | $-8,531,020 | $-8,832,499 |
| Gain On Sale Of Business | $0 | $7,547,905 | $0 | - |
| Other Special Charges | $690,712 | $-6,892,986 | $929,912 | $1,452,629 |
| Write Off | $0 | $78,760 | $0 | - |
| Gain On Sale Of Security | $105,064 | $-255,520 | $-501,374 | $-3,502,863 |
| Selling General And Administration | $671,330 | $1,453,257 | $4,905,989 | $2,599,398 |
| Other Gand A | $552,151 | $1,038,575 | $2,733,501 | $2,236,348 |
| Rent And Landing Fees | $4,381 | $2,599 | $12,307 | $0 |
| Salaries And Wages | $114,798 | $412,083 | $2,160,181 | $363,050 |
| Tax Provision | - | - | $0 | $0 |
| Gain On Sale Of Ppe | - | - | $0 | $623,553 |
| Restructuring And Mergern Acquisition | - | - | $0 | $376,699 |
| Impairment Of Capital Assets | - | - | - | $0 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-19,809,637 | $-12,153,213 | $-17,344,456 | $-12,925,920 |
| Total Assets | $10,835,697 | $11,745,650 | $6,337,094 | $114,330 |
| Total Non Current Assets | $9,816,837 | $10,549,808 | $6,237,080 | $84,792 |
| Current Assets | $1,018,860 | $1,195,842 | $100,014 | $29,538 |
| Inventory | $996,250 | $1,133,668 | $0 | - |
| Receivables | $20,454 | $61,524 | $23,251 | $1,771 |
| Taxes Receivable | $18,707 | $61,524 | $23,251 | $1,771 |
| Accounts Receivable | $1,747 | $0 | - | - |
| Cash Cash Equivalents And Short Term Investments | $2,156 | $650 | $2,317 | $27,767 |
| Cash And Cash Equivalents | $2,156 | $650 | $2,317 | $27,767 |
| Cash Financial | $2,156 | $650 | $2,317 | $27,767 |
| Prepaid Assets | - | $0 | $68,539 | $0 |
| Other Current Assets | - | - | $5,907 | - |
| Debt | ||||
| Net Debt | $8,437,165 | $7,009,617 | $8,929,098 | $8,991,326 |
| Total Debt | $14,060,365 | $12,935,406 | $14,524,892 | $9,019,093 |
| Long Term Debt And Capital Lease Obligation | $4,892,838 | $5,170,531 | $5,333,045 | $0 |
| Current Debt And Capital Lease Obligation | $9,167,527 | $7,764,875 | $9,191,847 | $9,019,093 |
| Current Debt | $8,439,321 | $7,010,267 | $8,931,415 | $9,019,093 |
| Other Current Borrowings | $2,071,631 | $4,010,267 | $8,931,415 | $9,019,093 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $30,645,334 | $23,898,863 | $23,681,550 | $13,040,250 |
| Total Non Current Liabilities Net Minority Interest | $4,892,838 | $5,170,531 | $5,333,045 | $-1 |
| Current Liabilities | $25,752,496 | $18,728,332 | $18,348,505 | $13,040,251 |
| Other Current Liabilities | $4,813,333 | $1,468,608 | $1,008,868 | $507,494 |
| Current Notes Payable | $6,367,690 | $3,000,000 | $7,715,858 | $8,223,888 |
| Payables And Accrued Expenses | $11,771,636 | $9,494,849 | $8,147,790 | $3,513,664 |
| Interest Payable | $2,495,337 | $523,680 | $151,925 | $194,407 |
| Payables | $4,783,656 | $4,929,416 | $7,805,865 | $3,129,257 |
| Accounts Payable | $4,783,656 | $4,929,416 | $7,805,865 | $3,129,257 |
| Other Non Current Liabilities | - | - | - | $-1 |
| Equity | ||||
| Common Stock Equity | $-20,439,053 | $-14,792,629 | $-19,903,872 | $-13,468,111 |
| Preferred Stock Equity | $629,416 | $2,639,416 | $2,559,416 | $542,191 |
| Total Equity Gross Minority Interest | $-19,809,637 | $-12,153,213 | $-17,344,456 | $-12,925,920 |
| Stockholders Equity | $-19,809,637 | $-12,153,213 | $-17,344,456 | $-12,925,920 |
| Gains Losses Not Affecting Retained Earnings | $556,249 | $-34,994 | $240,426 | $-371,909 |
| Other Equity Adjustments | $556,249 | $-34,994 | $240,426 | $-371,909 |
| Retained Earnings | $-101,184,142 | $-91,278,353 | $-94,966,809 | $-86,164,319 |
| Other | ||||
| Treasury Shares Number | $6,230,761 | $6,230,761 | $133,200 | $133,200 |
| Ordinary Shares Number | $662,501,405 | $440,752,302 | $274,124,622 | $125,509,810 |
| Share Issued | $668,732,166 | $446,983,063 | $274,257,822 | $125,643,010 |
| Tangible Book Value | $-20,439,053 | $-14,792,629 | $-19,903,872 | $-13,468,111 |
| Invested Capital | $-11,999,732 | $-7,782,362 | $-10,972,457 | $-4,449,018 |
| Working Capital | $-24,733,636 | $-17,532,490 | $-18,248,491 | $-13,010,713 |
| Capital Lease Obligations | $5,621,044 | $5,925,139 | $5,593,477 | $0 |
| Total Capitalization | $-19,809,637 | $-12,153,213 | $-17,344,456 | $-12,925,920 |
| Treasury Stock | $-623 | $-623 | $13 | $13 |
| Additional Paid In Capital | $80,122,590 | $76,476,643 | $74,795,112 | $73,055,579 |
| Capital Stock | $695,666 | $2,683,491 | $2,586,828 | $554,742 |
| Common Stock | $66,250 | $44,075 | $27,412 | $12,551 |
| Preferred Stock | $629,416 | $2,639,416 | $2,559,416 | $542,191 |
| Long Term Capital Lease Obligation | $4,892,838 | $5,170,531 | $5,333,045 | $0 |
| Current Capital Lease Obligation | $728,206 | $754,608 | $260,432 | - |
| Current Accrued Expenses | $6,987,980 | $4,565,433 | $341,925 | $384,407 |
| Investments And Advances | $4,518,127 | $4,518,127 | $78,760 | $78,760 |
| Net PPE | $5,298,710 | $6,031,681 | $6,158,320 | $6,032 |
| Accumulated Depreciation | $-861,624 | $-650,405 | $-287,881 | $-5,122 |
| Gross PPE | $6,160,334 | $6,682,086 | $6,446,201 | $11,154 |
| Machinery Furniture Equipment | $210,851 | $209,449 | $125,786 | $11,154 |
| Buildings And Improvements | $5,949,483 | $6,472,637 | $6,320,415 | $0 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $414,732 | $472,361 | $0 | - |
| Work In Process | $581,518 | $661,307 | $0 | - |
| Construction In Progress | - | - | - | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-1,697,232 | $-2,355,086 | $-1,564,361 | $-2,420,919 |
| Operating Activities | ||||
| Operating Cash Flow | $-1,697,232 | $-2,274,452 | $-1,448,363 | $-2,414,656 |
| Cash Flow From Continuing Operating Activities | $-1,697,232 | $-2,274,452 | $-1,448,363 | $-2,414,658 |
| Operating Gains Losses | $585,648 | $-6,637,466 | $1,431,286 | $4,955,492 |
| Investing Activities | ||||
| Investing Cash Flow | $0 | $-80,634 | $-115,998 | $493,623 |
| Cash Flow From Continuing Investing Activities | $0 | $-80,634 | $-115,998 | $493,623 |
| Capital Expenditure | - | $-80,634 | $-115,998 | $-6,263 |
| Financing Activities | ||||
| Financing Cash Flow | $1,698,738 | $2,353,419 | $1,404,703 | $1,340,479 |
| Cash Flow From Continuing Financing Activities | $1,698,738 | $2,353,419 | $1,404,703 | $1,340,479 |
| Issuance Of Capital Stock | - | $0 | $437,012 | $826,064 |
| Net Common Stock Issuance | - | $0 | $437,012 | $291,064 |
| Common Stock Issuance | - | $0 | $437,012 | $291,064 |
| Net Preferred Stock Issuance | - | - | - | $535,000 |
| Preferred Stock Issuance | - | - | - | $535,000 |
| Other | ||||
| Issuance Of Debt | $1,698,738 | $2,353,419 | $967,691 | $822,916 |
| Interest Paid Supplemental Data | $0 | $0 | $0 | $0 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $2,156 | $650 | $2,317 | $27,767 |
| Beginning Cash Position | $650 | $2,317 | $27,767 | $334,969 |
| Effect Of Exchange Rate Changes | $0 | $0 | $134,208 | $273,372 |
| Changes In Cash | $1,506 | $-1,667 | $-159,658 | $-580,574 |
| Net Issuance Payments Of Debt | $1,698,738 | $2,353,419 | $967,691 | $514,415 |
| Net Short Term Debt Issuance | $1,698,738 | $2,353,419 | $967,691 | $0 |
| Short Term Debt Issuance | $1,698,738 | $2,353,419 | $967,691 | $0 |
| Net PPE Purchase And Sale | $0 | $-80,634 | $-115,998 | $533,113 |
| Purchase Of PPE | $0 | $-80,634 | $-115,998 | $-6,263 |
| Change In Working Capital | $24,161 | $-821,195 | $3,948,291 | $-420,987 |
| Change In Other Current Assets | $0 | $5,907 | $-44,553 | $0 |
| Change In Payables And Accrued Expense | $491,141 | $276,300 | $4,082,976 | $-551,808 |
| Change In Accrued Expense | $-272,426 | $146,316 | $103,427 | $-102,144 |
| Change In Interest Payable | $-272,426 | $146,316 | $103,427 | $97,664 |
| Change In Payable | $763,567 | $129,984 | $3,979,549 | $-449,664 |
| Change In Account Payable | $763,567 | $129,984 | $3,979,549 | $-449,664 |
| Change In Prepaid Assets | $0 | $68,539 | $-68,539 | $132,039 |
| Change In Inventory | $-508,050 | $-1,133,668 | $0 | - |
| Change In Receivables | $41,070 | $-38,273 | $-21,593 | $-1,218 |
| Changes In Account Receivables | $-1,747 | $0 | - | - |
| Other Non Cash Items | $5,713,884 | $1,289,146 | $1,227,167 | $1,517,580 |
| Asset Impairment Charge | $1,884,864 | $78,760 | $0 | $0 |
| Depreciation Amortization Depletion | $0 | $127,847 | $294,934 | $2,708 |
| Depreciation And Amortization | $0 | $127,847 | $294,934 | $2,708 |
| Gain Loss On Investment Securities | $-105,064 | $255,520 | $501,374 | $3,502,863 |
| Net Income From Continuing Operations | $-9,905,789 | $3,688,456 | $-8,531,020 | $-8,832,499 |
| Stock Based Compensation | - | $0 | $180,979 | $363,050 |
| Net Long Term Debt Issuance | - | - | $912,952 | $514,415 |
| Long Term Debt Issuance | - | - | $912,952 | $822,916 |
| Net Investment Purchase And Sale | - | - | $0 | $-39,490 |
| Purchase Of Investment | - | - | $0 | $-39,490 |
| Sale Of PPE | - | - | $0 | $539,376 |
| Depreciation | - | - | $294,934 | $2,708 |
| Repayment Of Debt | - | - | - | $-308,501 |
| Long Term Debt Payments | - | - | - | $-308,501 |
| Change In Other Current Liabilities | - | - | - | $0 |
| Amortization Cash Flow | - | - | - | $0 |
| Amortization Of Intangibles | - | - | - | $0 |
Fetched: 2026-02-02